Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of GLP-1 receptor agonist exenatide on cerebral blood flow and oxygenation in healthy older adults
2016-001221-14Phase 2Completed
- Sponsor
- Herlev & Gentofte Hospital
- Start
- Mar 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of exenatide, sponsored by Herlev & Gentofte Hospital. Primary endpoints: Change in mean blood flow velocity in middle cerebral artery and Change in cortical oxygenation. Started Mar 2016; status: completed.
02
Drugs
exenatide
Beyond the preview
Go deeper on 2016-001221-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001221-14.